Evaluating the GCN5b bromodomain as a novel therapeutic target against the parasite Toxoplasma gondii.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental parasitology"
DOI: 10.1016/j.exppara.2020.107868
Abstract: Toxoplasma gondii is a protozoan parasite of great importance in human and veterinary health. The frontline treatment of antifolates suffers a variety of drawbacks, including toxicity and allergic reactions, underscoring the need to identify novel… read more here.
Keywords: gcn5b; toxoplasma gondii; gcn5b bromodomain; bromodomain ... See more keywords